Cargando…

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease

BACKGROUND: A comprehensive analysis of the effects of inhaled corticosteroids (ICS) on COPD in a real-world setting is required due to safety concerns regarding ICS in COPD. This study aimed to explore the impact of ICS on the prognosis of Asian COPD patients in the real-life world. METHODS: We exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ji Won, Hong, Yoonki, Rhee, Chin Kook, Choi, Hye Sook, Kim, Kyungjoo, Yoo, Kwang Ha, Jung, Ki-Suck, Park, Joo Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163892/ https://www.ncbi.nlm.nih.gov/pubmed/37159577 http://dx.doi.org/10.2147/COPD.S388367

Ejemplares similares

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19
por: Kim, Youlim, et al.
Publicado: (2022)

Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids
por: Jo, Yong Suk, et al.
Publicado: (2020)

Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study
por: Park, Hye Jung, et al.
Publicado: (2018)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Effect of low protein intake on acute exacerbations in mild to moderate chronic obstructive pulmonary disease: data from the 2007–2012 KNHANES
por: Park, Sojung, et al.
Publicado: (2021)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Efficacy and predictors of response to inhaled corticosteroid treatment for chronic cough
por: Hong, Ji Young, et al.
Publicado: (2019)

Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis
por: Lee, Jongmin, et al.
Publicado: (2019)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
por: Choi, Hye Sook, et al.
Publicado: (2019)

The global status of chronic obstructive pulmonary disease
por: Rhee, Chin Kook, et al.
Publicado: (2021)

Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry
por: Kim, Joo Kyung, et al.
Publicado: (2016)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications
por: Lee, Jin Hwa, et al.
Publicado: (2017)

Ambulatory oxygen therapy with documented self-monitoring of oxygen use improves health status among patients with chronic obstructive pulmonary disease
por: Kim, Youlim, et al.
Publicado: (2022)

Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2023)

Heterogeneity of asthma and COPD overlap
por: Kim, Min-Hye, et al.
Publicado: (2018)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Short-term Evaluation of a Comprehensive Education Program Including Inhaler Training and Disease Management on Chronic Obstructive Pulmonary Disease
por: Yoo, Kwang Ha, et al.
Publicado: (2017)

Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease
por: Joo, Dong-Hyun, et al.
Publicado: (2021)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Comparison of clinical characteristics between chronic bronchitis and non-chronic bronchitis in patients with chronic obstructive pulmonary disease
por: Choi, Joon Young, et al.
Publicado: (2022)

Regular follow-up visits reduce the risk for asthma exacerbation requiring admission in Korean adults with asthma
por: Park, Hye Jung, et al.
Publicado: (2018)

Nationwide quality assessment of treatment for chronic obstructive pulmonary disease
por: Kim, Kyu Yean, et al.
Publicado: (2020)

Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Joon Young, et al.
Publicado: (2023)

The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data
por: Kim, JinHee, et al.
Publicado: (2013)

Natural course of early COPD
por: Rhee, Chin Kook, et al.
Publicado: (2017)

Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD
por: Choi, Joon Young, et al.
Publicado: (2023)

Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
por: Joo, Hyonsoo, et al.
Publicado: (2022)

Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study
por: Kim, Jinhee, et al.
Publicado: (2013)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5r6gsfdlllj3indnmaeretvd6f